Full-Time

Credit Underwriter

Posted on 9/10/2025

Deadline 7/11/27
NJEDA

NJEDA

Compensation Overview

$71.6k - $80.8k/yr

No H1B Sponsorship

Philadelphia, PA, USA + 3 more

More locations: Newark, NJ, USA | Franklin Township, NJ, USA | Trenton, NJ, USA

Hybrid

Hybrid work; up to 2 telecommute days per week; NJ residency required.

Category
Finance & Banking (1)
Requirements
  • Knowledge in Commercial Credit including: understanding of GAAP, income, balance sheet and cash flow statements, personal net worth statements, and tax returns
  • Ability to understand loan documentation, appraisals and environmental reports
  • Knowledge of sound commercial lending and underwriting principles, industry standards and regulatory compliance
  • Ability to evaluate and interpret market and feasibility studies
  • Ability to understand and interpret real estate appraisals
  • Must possess a solution-oriented mindset to allow creative thinking
  • Demonstrates a leadership and ownership mindset
  • Ability to understand loan approval procedures, closing and disbursement processes
  • Demonstrates interpersonal and negotiation skills when dealing with external business professionals and NJEDA staff
  • Ability to communicate effectively both verbally and in writing; proficient in grammar, spelling and editing; and foster communications with business professionals and EDA staff
  • Ability to prioritize workload, must be highly organized, detail-oriented, handle various tasks simultaneously and work independently within limited time constraints with minimal supervision
  • Must be able to maintain confidentiality and deal effectively and diplomatically with business professionals and EDA staff
  • Demonstrates respectful behavior and promotes teamwork and communication to encourage an interactive, cooperative, collaborative and customer focused work environment among division, EDA staff and external customers
  • Analytical skills with a keen focus on details and audit trails
  • Minimum five years commercial banking and real estate lending experience including client relationship management
  • Advanced degree or industry specific certification may be substituted for 1 year of experience
  • Bachelor’s Degree with emphasis in business, planning, project management, public administration, finance, or closely related field and/or equivalent professional experience
  • Formal credit training preferred
  • Proficient in Microsoft Office Suite, Moody’s Financial Analyst skills, CRM, Lexis Nexus, and the ability to learn new software packages
  • Travel expected when necessary for business operations
  • Must complete annual self-assessment as required
  • Foreign degrees/transcripts must be evaluated by a reputable evaluation service at your own expense and submitted prior to a start date
  • Must comply with New Jersey First Act residency requirement
  • Must complete Outside Activity Questionnaire annually
  • Must review the required New Jersey State Ethics Guidelines
Responsibilities
  • Reviews applications for completeness, evaluates loan requests and determines how to best structure the loan/guarantee if not determined in advance
  • Follows up with applicant, lending partner, or business banking officer for additional information
  • May conduct site visits with applicants to discuss projects
  • Interviews applicants regarding business, financial/operational matters, and personal financial information
  • Negotiates collateral or loan conditions when appropriate
  • Prepares loan underwriting including financial statements, business and personal cash flow analysis, collateral analysis and the strengths, weaknesses, and mitigants of each loan to be approved, analysis of public policy considerations, and compliance with internal program policies
  • Prepares financial reviews in support of the EDA’s tax incentive programs. Presents written analyses at internal committees and provides support at EDA Board
  • Provides insight and recommendations in respect to loan structure, risk identification and mitigation
  • Provides advice on loan risk mitigation to internal and when appropriate external partners
  • Represents the Underwriting department when appropriate at external meetings with lending partners
  • Reviews draft commitment letters prepared by Closing Services to ensure consistency with credit approval
  • Responds to applicant questions/challenges, handles modifications and obtains approval for the same when applicable
  • Monitors outstanding loan commitments to ensure projects proceed and loans are closed in a timely basis
  • Collaborates with Closing Services to ensure applicant’s compliance with conditions contained in commitment letters are met prior to loan closing
  • Approves closing memorandum and recommends approval to Managing Director and Closing Services
  • Provides training and mentorship to less experienced underwriting officers
  • Success of this role will be measured based on the quality of analyses presented to Managing Director for review and approval
  • Success is measured by the continued development of the officer and overall success in meeting department policies and procedures per quality control reviews

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Evan Weiss CEO appointment leverages fiscal expertise for efficient fund deployment.
  • Covenant VC invests in Hill Research AI with NJEDA, proving public-private model.
  • NJ LEND pilot offers $5M for NJ business real estate and equipment purchases.

What critics are saying

  • Evan Weiss lacks deep tech VC expertise, disrupting AI initiatives in 6-12 months.
  • Plug and Play sole operator fails, halting $3.8M AI and $12.55M SIC programs.
  • Weak 285 AI Challenge applications lead to $3.34M underutilization and cuts.

What makes NJEDA unique

  • NJEDA funds AI startups via $20M AI Hub Fund with CoreWeave match.
  • NJEDA approves $12.55M for NJ AIM medtech and New Baby NJ maternal SICs.
  • NJEDA backs Plug and Play AI Challenge awarding 10 social good AI teams.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Hybrid Work Options

Flexible Work Hours

Wellness Program

Company News

PR Newswire
Apr 6th, 2026
New Jersey awards 10 AI startups up to $3.34M in non-dilutive funding for social good solutions

Plug and Play has completed the New Jersey AI Innovation Challenge Demo Day, where 10 winning teams presented minimum viable products developed through the statewide programme supported by the New Jersey Economic Development Authority. The initiative received 285 applications from startups, universities and corporations across New Jersey. The winning solutions address government services, clinical intelligence, diabetes care, climate resilience, student support, cybersecurity and energy forecasting. Teams include AgentGov's fraud detection system for government, CardioLink's cardiovascular care intelligence and GlucoSync's diabetes treatment support platform. Winners will receive milestone-based, non-dilutive follow-on funding as they progress towards pilot demonstration or commercialisation in New Jersey. The NJEDA has allocated up to $3.34 million in sub-grant funding for participating teams, administered by Plug and Play.

Covenant VC
Apr 2nd, 2026
Covenant Venture Capital invests in AI firm Hill Research with NJEDA backing

Covenant Venture Capital has completed a strategic investment in Hill Research, an AI company specialising in clinical development technology, in partnership with the New Jersey Economic Development Authority. The investment was led by René Bastón, Venture Partner at Covenant. Hill Research integrates agentic AI with biometrics to support clinical development from trial design through regulatory submission, automating regulated workflows whilst maintaining submission-grade precision for compliance-driven environments. The transaction reflects Covenant's focus on AI infrastructure companies positioned for structural technology adoption and sustained enterprise demand. The partnership with NJEDA underscores public-private collaboration in accelerating innovation and regional growth. Covenant Venture Capital, a New Jersey Qualified Venture Fund, backs deep tech and digital health companies at the intersection of breakthrough technology and commercialisation.

PR Newswire
Jan 21st, 2026
Evan Weiss named CEO of New Jersey Economic Development Authority

Evan Weiss, a board member of New Jersey Community Capital, has been named chief executive officer of the New Jersey Economic Development Authority by Governor-elect Mikie Sherrill. Weiss currently serves as president and CEO of the Newark Alliance, Newark's leading private sector-led economic development organisation. He previously worked as senior advisor for finance and major projects to Governor Phil Murphy, managing the state's fiscal response to COVID-19 and establishing New Jersey as a base for the US offshore wind industry. Before joining the Governor's administration, Weiss was director at the Pennsylvania Economy League and HJA Strategies, developing turnaround strategies for distressed cities including Newark, Atlantic City and Trenton. He holds a degree from the University of Chicago.

Vivid Bling
Jan 9th, 2026
NJEDA Board approves over $12.5M in funding to support innovative medtech and maternal health startups | Rowan Today

NJEDA Board approves over $12.5M in funding to support innovative medtech and maternal health startups | Rowan today. The New Jersey Economic Development Authority (NJEDA) Board recently approved a $12.55 million commitment into two Strategic Innovation Centers (SICs) focused on medical technology and maternal health, facilitating startup creation and bolstering New Jersey's innovation ecosystem. The New Jersey Accelerator for Innovation in Medtech (NJ AIM), a multi-location SIC in Camden and Mullica Hill, will support the research, development, and commercialization of novel medical technologies and devices. The New Baby New Jersey SIC, which will be located in Trenton's Maternal and Infant Health Innovation Center (MIHIC), will assist early-stage companies advance groundbreaking maternal and infant health solutions. "Throughout the Murphy administration, New Jersey has invested heavily in creating environments where entrepreneurs can thrive, opening pathways to capital, encouraging collaboration, and leveraging the strength of the state's academic institutions and private sector partners," said NJEDA Acting Chief Executive Officer Mary Maples. "The NJEDA's latest investments into NJ AIM and the New Baby New Jersey SIC further establish the state's leadership in the medtech and maternal health sectors, advancing scientific breakthroughs, creating jobs, and bolstering the regional economy." The NJ AIM and New Baby New Jersey SIC programs, managed by Plug and Play, will include a combination of services, including workshops, mentorship sessions, business development services, education opportunities, access to unique equipment and industry partners, and investment opportunities. The programs will accelerate two cohorts of startups per year comprised of no less than 20 independent companies per cohort in both Camden and Trenton. 20 percent of participating companies must be from New Jersey, and the remaining participants will include companies from out of state that may relocate to New Jersey with support from resources that support early-stage startups, such as NJ Accelerate. The NJEDA will commit up to $5.5 million to invest in NJ AIM and New Baby New Jersey SIC companies and $2.25 million, matched by SIC partner Rowan University, to support the accelerator programs. Additionally, the NJEDA will invest $1.5 million in a new venture studio operated by NLC Ventures, a leading global venture builder in health technology, which will support the development of new medtech and maternal health companies in the state. The NJEDA will reserve $3 million for an early-phase maternal and infant health pre-venture development and early-stage initiative located in Trenton to include programmatic and technical support administered by a third-party. "New Jersey is making a clear statement about its commitment to building the next generation of medical technology companies," said NLC Ventures USA Director Jaap Haemers. "Through this venture studio, we will work hands-on with founders to translate breakthrough science into scalable companies, while embedding them in a world-class ecosystem of clinical partners, universities, and investors. We're proud to partner with NJEDA to help position New Jersey as a global launchpad for health innovation." The NJ AIM SIC will encompass 8,500 square feet of space within two locations in Camden: the Joint Health Sciences Center and the Cooper Medical School of Rowan University. It will also have space on Rowan University's West Campus in Mullica Hill, alongside the Shreiber School of Veterinary Medicine. The SIC will include comprehensive laboratory, diagnostic, and testing spaces for research and development of new technologies in a collaborative environment. Cooper University Health Care will serve as the anchor commercial affiliate and the Rowan Foundation will invest in select participating accelerator companies. "Innovation begins with bold investment," said Rowan University President Ali A. Houshmand. "The future of New Jersey is built on collaboration and partnerships that make a difference. Backed by the New Jersey Economic Development Authority and strengthened by private industry, early-stage investors, and public entities like ours, together we will shape a stronger, more vibrant New Jersey." The New Baby New Jersey SIC will include 5,000 square feet of space within the MIHIC. In collaboration with public and private stakeholders, the location will provide first-in-class research and development focused on maternal health care, driving breakthrough solutions in maternal care equity, digital health, doula support, perinatal mental health, and public benefits access. The SIC will further the state's national leadership in maternal and infant health innovation, leveraging startups, academic institutions, public agencies, and community voices to advance maternal health equity and inventive medical technologies. "We're incredibly proud to be part of this pivotal moment in New Jersey's innovation journey. The accelerator is more than a program - it's a launchpad for bold ideas that have the power to reshape maternal health across our state," said Lisa Asare, CEO of the New Jersey Maternal and Infant Health Innovation Authority (NJMIHIA). "Our vision is a world where every mother and baby flourish. NJEDA's investments to scale maternal health companies and support entrepreneurs is critical - not only to uplift NJ's mothers and babies, but also strengthening the infrastructures that deliver on the highest level of care." With over 60 offices globally and partnerships with more than 550 corporations, Plug and Play runs more than 100 accelerator programs annually across sectors like AI, fintech, health, and energy. The NJEDA previously partnered with Plug and Play on the Fintech Accelerator at Stevens Institute of Technology (NJ FAST), a financial technology and insurance technology SIC. "New Jersey is doubling down on startup innovation where it matters most: helping breakthrough medical technologies reach patients and accelerating solutions that improve health outcomes," said Plug and Play Partner and Chief Revenue Officer Michael Olmstead. "Plug and Play is proud to partner with NJEDA, Rowan University, and Cooper University Health Care to give founders what they need to scale: deep clinical and academic collaboration, hands-on commercialization support, and direct pathways to customers and capital." SICs are facilities that support research and development, innovation, and entrepreneurship through mentorship, networking opportunities, hands-on training, business support services, and education opportunities. SICs can be accelerators, incubators, or research centers. Having a physical location where entrepreneurs can collaborate will help support new, diverse innovators and help drive long-term economic growth. The NJEDA has announced investments into 12 SICs in New Jersey, focused on industries such as artificial intelligence, fintech, aerospace, life sciences, and biotech. To learn more about the NJEDA's SIC initiative, visit About the NJEDA The New Jersey Economic Development Authority (NJEDA) serves as the State's principal agency for driving economic growth. The NJEDA is committed to making New Jersey a national model for inclusive and sustainable economic development by focusing on key strategies to help build strong and dynamic communities, create good jobs for New Jersey residents, and provide pathways to a stronger and fairer economy. Through partnerships with a diverse range of stakeholders, the NJEDA creates and implements initiatives to enhance the economic vitality and quality of life in the State and strengthen New Jersey's long-term economic competitiveness.

New Jersey Economic Development Authority (NJEDA)
Jan 7th, 2026
New Jersey backs medtech and maternal health startups with $12.5M funding

The New Jersey Economic Development Authority has approved $12.55 million in funding for two Strategic Innovation Centers focused on medical technology and maternal health. The investment will support startup creation and strengthen New Jersey's innovation ecosystem. The New Jersey Accelerator for Innovation in Medtech will operate across Camden and Mullica Hill, supporting research and commercialisation of medical technologies. The New Baby New Jersey centre, located in Trenton's Maternal and Infant Health Innovation Centre, will advance maternal and infant health solutions. Managed by Plug and Play, both programmes will accelerate two cohorts annually, each comprising at least 20 companies. At least 20% of participants must be New Jersey-based. The NJEDA will invest up to $5.5 million directly in participating companies, with additional funding supporting accelerator programmes and a new venture studio operated by NLC Ventures.

INACTIVE